{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:27:15Z","timestamp":1792099635849,"version":"4.4.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosgenetics.org"],"crossmark-restriction":false},"short-container-title":["PLoS Genet"],"DOI":"10.1371\/journal.pgen.1003632","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T20:47:10Z","timestamp":1375390030000},"page":"e1003632","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgen.corrections_policy","source":"Crossref","is-referenced-by-count":145,"title":["Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry Disease"],"prefix":"10.1371","volume":"9","author":[{"given":"Jan","family":"Lukas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Katrin","family":"Giese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arseni","family":"Markoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Grittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Kolodny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Mascher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Wree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viatcheslav","family":"Saviouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Rolfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of Later-Onset Fabry Disease Revealed by Newborn Screening","volume":"79","author":"M Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/8904_2012_130","article-title":"Newborn Screening for Lysosomal Storage Disorders in Hungary","volume":"6","author":"J Wittmann","year":"2012","journal-title":"JIMD Rep"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20070479","article-title":"Mutant \u03b1-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin","volume":"406","author":"S Ishii","year":"2007","journal-title":"Biochem J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","article-title":"Results of a Nationwide Screening for Anderson-Fabry Disease among Dialysis Patients","volume":"15","author":"P Kotanko","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","article-title":"Fabry disease: a review of current management strategies","volume":"103","author":"A Mehta","year":"2010","journal-title":"QJM"},{"key":"ref6","first-page":"3661794","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study","author":"A Rolfs","year":"2005","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry&apos;s disease in men with left ventricular hypertrophy","volume":"3;333","author":"S Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0925-4439(00)00024-7","article-title":"Characterization of two alpha-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease","volume":"1501","author":"R Kase","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry","volume":"40","author":"K Sims","year":"2009","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"B Sachdev","year":"2002","journal-title":"Circulation"},{"key":"ref11","first-page":"1186","article-title":"Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease","volume":"53","author":"CM Eng","year":"1993","journal-title":"Am J Hum Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/BF03401993","article-title":"Twenty Novel Mutations in the a-Galactosidase A Gene Causing Fabry Disease","volume":"5","author":"AK Topaloglu","year":"1999","journal-title":"Mol Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/STROKEAHA.110.579409","article-title":"Belgian Fabry Study: Prevalence of Fabry Disease in a Cohort of 1000 Young Patients with Cerebrovascular Disease","volume":"41","author":"R Brouns","year":"2010","journal-title":"Stroke"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1096-7192(03)00136-7","article-title":"Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma","volume":"80","author":"R Froissart","year":"2003","journal-title":"Mol Genet Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/humu.10275","article-title":"Fabry Disease: Characterization of a-Galactosidase A Double Mutations and the D313Y Plasma Enzyme Pseudodeficiency Allele","volume":"22","author":"M Yasuda","year":"2003","journal-title":"Hum Mutat"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/STROKEAHA.109.570499","article-title":"Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study\u2013screening genetic conditions in Portuguese young stroke patients","volume":"41","author":"MV Baptista","year":"2010","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2082; author reply 2082","DOI":"10.1016\/j.jacc.2008.02.050","article-title":"Enzyme Activity for Determination of Presence of Fabry Disease in Women Results in 40% False-Negative Results","volume":"51","author":"GE Linthorst","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"JM Aerts","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/ndt\/gfq306","article-title":"Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy","volume":"26","author":"MD Sanchez-Ni\u00f1o","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref20","first-page":"741","article-title":"Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease","volume":"1802","author":"SM Rombach","year":"2010","journal-title":"Biochem Biophys Acta"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/humu.9520","article-title":"Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone","volume":"29","author":"M Shimotori","year":"2008","journal-title":"Hum Mutat"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1034\/j.1399-0004.2001.600107.x","article-title":"Identification of fifteen novel mutations and genotype-phenotype relationship in Fabry disease","volume":"60","author":"GM Altarescu","year":"2001","journal-title":"Clin Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","article-title":"The Molecular Defect Leading to Fabry Disease: Structure of Human \u03b1-Galactosidase","volume":"337","author":"SC Garman","year":"2004","journal-title":"J Mol Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00439-005-1300-5","article-title":"Fabry disease: correlation between structural changes in \u03b1-galactosidase, and clinical and biochemical phenotypes","volume":"117","author":"F Matsuzawa","year":"2005","journal-title":"Hum Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/jhg.2010.5","article-title":"Prediction of the clinical phenotype of Fabry disease based on protein sequential and structural information","volume":"55","author":"S Saito","year":"2010","journal-title":"J Hum Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1172-5-36","article-title":"Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study","volume":"5","author":"G Andreotti","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbadis.2009.11.003","article-title":"Functional studies of new <italic>GLA<\/italic> gene mutations leading to conformational Fabry disease","volume":"1802","author":"C Filoni","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/FPC.0b013e32830500f4","article-title":"Prediction of response of mutated alpha-galactosidase A to a pharmacological chaperone","volume":"18","author":"SH Shin","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10545-009-1077-0","article-title":"The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell lines","volume":"32","author":"ER Benjamin","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/humu.21530","article-title":"A Pharmacogenetic Approach to Identify Mutant Forms of \u03b1-Galactosidase A that Respond to a Pharmacological Chaperon for Fabry Disease","volume":"32","author":"X Wu","year":"2011","journal-title":"Hum Mutat"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"IA Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"ref32","unstructured":"Desnick RJ, Ioannou YA, Eng CM (2001) The metabolic and molecular basis of inherited disease, ed 8, (New York, USA, McGraw-Hill), pp. 3733\u20133774."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1651-2227.2007.00198.x","article-title":"Structure\u2013function relationships in \u03b1-galactosidase A","author":"SC Garman","year":"2007","journal-title":"Acta Paediatrica"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbadis.2010.09.007","article-title":"Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy","volume":"1812","author":"MJ van Breemen","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/8904_2012_154","article-title":"Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease","volume":"7","author":"M Niemann","year":"2013","journal-title":"JIMD Rep"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/ckj\/sfs115","article-title":"Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene","volume":"5","author":"J Lukas","year":"2012","journal-title":"Clin Kidney J"},{"key":"ref37","first-page":"784","article-title":"Identification of point mutations in the a-Galactosidase A Gene in Classical and Atypical hemizygotes with Fabry Disease","volume":"47","author":"H Sakuraba","year":"1990","journal-title":"Am J Hum Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0076-6879(03)01069-3","article-title":"Cell-Based Screening of Active-Site Specific Chaperone for the Treatment of Fabry Disease","volume":"363","author":"JQ Fan","year":"2003","journal-title":"Methods Enzymol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF03401671","article-title":"Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes","volume":"3","author":"CM Eng","year":"1997","journal-title":"Mol Med"},{"key":"ref40","first-page":"157","article-title":"Fabry&apos;s disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes","volume":"81","author":"RJ Desnick","year":"1973","journal-title":"J Lab Clin Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1016\/S0021-9258(19)44613-9","article-title":"Purification and Properties of Human \u03b1-Galactosidases","volume":"217","author":"E Beutler","year":"1972","journal-title":"J Biol Chem"}],"container-title":["PLoS Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pgen.1003632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T20:14:31Z","timestamp":1646252071000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1003632"}},"subtitle":[],"editor":[{"given":"Atul","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgen.1003632","relation":{},"ISSN":["1553-7404"],"issn-type":[{"value":"1553-7404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,1]]}}}